[1] 唐家琢,李满,王卫星,等.Treg在肝移植受者免疫耐受中的研究进展[J].中华肝脏外科手术学电子杂志,2021,10(3):337-339.
[2] 泉余,蒋师放,夏仁培,等.肝移植临床免疫抑制剂及新药研究进展[J].器官移植,2020,11(6):663-670.
[3] MERLIN S, BHARGAVA KK, RANALDO G, et al. Kupffer cell transplantation in mice for elucidating monocyte/macrophage biology and for potential in cell or gene therapy. Am J Pathol. 2016;186(3):539-551.
[4] JIANG Y, QUE W, ZHU P, et al. The role of diverse liver cells in liver transplantation tolerance. Front Immunol. 2020;11:1203.
[5] Kupffer CV. Ueber Sternzellen der Leber. Arch Mikrosk Anat. 1876; 12:353-358.
[6] BILZER M, ROGGEL F, GERBES AL. Role of Kupffer cells in host defense and liver disease. Liver Int. 2006;26(10):1175-1186.
[7] GOMEZ PERDIGUERO E, KLAPPROTH K, SCHULZ C, et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature. 2015;518(7540):547-551.
[8] KAZANKOV K, JØRGENSEN SMD, THOMSEN KL, et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol. 2019;16(3):145-159.
[9] 王茜,何浩,宋文刚.枯否细胞的负向免疫调节作用[J].细胞与分子免疫学杂志,2010,26(6):611-612.
[10] NAITO M, HASEGAWA G, EBE Y, et al. Differentiation and function of Kupffer cells. Med Electron Microsc. 2004;37(1):16-28.
[11] BENNETT H, TROUTMAN TD, SAKAI M, et al. Epigenetic regulation of Kupffer cell function in health and disease. Front Immunol. 2021; 11:609618.
[12] WANG C, MA C, GONG L, et al. Macrophage polarization and its role in liver disease. Front Immunol. 2021;12:803037.
[13] ZWICKER C, BUJKO A, SCOTT CL. Hepatic macrophage responses in inflammation, a function of plasticity, heterogeneity or both? Front Immunol. 2021;12:690813.
[14] DIXON LJ, BARNES M, TANG H, et al. Kupffer cells in the liver. Compr Physiol. 2013;3(2):785-797.
[15] MANTOVANI A, SICA A, SOZZANI S, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25(12):677-686.
[16] KINARET PAS, SCALA G, FEDERICO A, et al. Carbon nanomaterials promote M1/M2 macrophage activation. Small. 2020;16(21):e1907609.
[17] WANG Q, WEI S, ZHOU H, et al. Hyperglycemia exacerbates acetaminophen-induced acute liver injury by promoting liver-resident macrophage proinflammatory response via AMPK/PI3K/AKT-mediated oxidative stress. Cell Death Discov. 2019;5:119.
[18] HUANG X, LI Y, FU M, et al. Polarizing macrophages in vitro. Methods Mol Biol. 2018;1784:119-126.
[19] DOU L, SHI X, HE X, et al. Macrophage phenotype and function in liver disorder. Front Immunol. 2020;10:3112.
[20] DOHERTY DG. Immunity, tolerance and autoimmunity in the liver: a comprehensive review. J Autoimmun. 2016;66:60-75.
[21] 蔡佳晖,王经琳,任昊桢,等.枯否细胞在肝移植脂肪供肝的缺血再灌注损伤中的作用研究进展[J].肝胆胰外科杂志,2021,33(1):56-60.
[22] URATA K, BRAULT A, ROCHELEAU B, et al. Role of Kupffer cells in the survival after rat liver transplantation with long portal vein clamping times. Transpl Int. 2000;13(6):420-427.
[23] 张安元,刘一鸣,龚建平.Kupffer细胞与肝脏移植的研究进展[J].世界华人消化杂志,2015,23(12):1917-1923.
[24] PEREZ R, JOHNSON J, WINKLER JD, et al. Kupffer cell-mediated lymphocyte apoptosis: a PGE2-dependent mechanism of portal venous transfusion-induced immunosuppression? J Surg Res. 1998;78(1):37-41.
[25] GREENBERG S, GRINSTEIN S. Phagocytosis and innate immunity. Curr Opin Immunol. 2002;14(1):136-145.
[26] GORDON S. Pattern recognition receptors: doubling up for the innate immune response. Cell. 2002;111(7):927-930.
[27] RAVICHANDRAN KS. Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways. Immunity. 2011;35(4):445-455.
[28] HOCHREITER-HUFFORD A, RAVICHANDRAN KS. Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harb Perspect Biol. 2013;5(1):a008748.
[29] 李静,季菊玲.肝脏巨噬细胞及其在肝损伤中的作用[J].世界华人消化杂志,2017,25(14):1223-1230.
[30] TIETJEN GT, GONG Z, CHEN CH, et al.Molecular mechanism for differential recognition of membrane phosphatidylserine by the immune regulatory receptor Tim4. Proc Natl Acad Sci U S A. 2014;111(15):E1463-E1472.
[31] LI XQ, LI XH, DUAN SG, et al. Effect of inhibiting TIM-4 function in Kupffer cells on liver graft rejection in mice. Nan Fang Yi Ke Da Xue Xue Bao. 2016;37(4):451-459.
[32] XU XS, FENG ZH, CAO D, et al. SCARF1 promotes M2 polarization of Kupffer cells via calcium-dependent PI3K-AKT-STAT3 signalling to improve liver transplantation. Cell Prolif. 2021;54(4):e13022.
[33] BRENNER C, GALLUZZI L, KEPP O, et al. Decoding cell death signals in liver inflammation. J Hepatol. 2013;59(3):583-594.
[34] AYALA A, PERRIN MM, ERTEL W, et al. Differential effects of hemorrhage on Kupffer cells: decreased antigen presentation despite increased inflammatory cytokine (IL-1, IL-6 and TNF) release. Cytokine. 1992;4(1):66-75.
[35] RONCA V, WOOTTON G, MILANI C, et al. The immunological basis of liver allograft rejection. Front Immunol. 2020;11:2155.
[36] WU H, XU X, LI J, et al. TIM4 blockade of KCs combined with exogenous TGFβ injection helps to reverse acute rejection and prolong the survival rate of mice receiving liver allografts. Int J Mol Med. 2018;42(1):346-358.
[37] LI J, GONG J, LI P, et al. Knockdown of microRNA-155 in Kupffer cells results in immunosuppressive effects and prolongs survival of mouse liver allografts. Transplantation. 2014;97(6):626-635.
[38] GAO B, JEONG WI, TIAN Z. Liver: an organ with predominant innate immunity. Hepatology. 2008;47(2):729-736.
[39] HADDAD A, WILSON AM. Biochemistry, Complement// StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2020.
[40] THORGERSEN EB, BARRATT-DUE A, HAUGAA H, et al. The role of complement in liver injury, regeneration, and transplantation. Hepatology. 2019;70(2):725-736.
[41] DEMETRIS AJ, BELLAMY C, HÜBSCHER SG, et al. 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection. Am J Transplant. 2016;16(10):2816-2835.
[42] KRAMS SM, MARTINEZ OM. Apoptosis as a mechanism of tissue injury in liver allograft rejection. Semin Liver Dis. 1998;18(2):153-167.
[43] TANNAPFEL A, KOHLHAW K, EBELT J, et al. Apoptosis and the expression of Fas and Fas ligand (FasL) antigen in rejection and reinfection in liver allograft specimens. Transplantation. 1999;67(7):1079-1083.
[44] MIYAGAWA-HAYASHINO A, TSURUYAMA T, EGAWA H, et al. FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts. Am J Pathol. 2007;171(5):1499-1508.
[45] SUN Z, WADA T, MAEMURA K, et al. Hepatic allograft-derived Kupffer cells regulate T cell response in rats. Liver Transpl. 2003;9(5):489-497.
[46] CHEN Y, LIU Z, LIANG S, et al.Role of Kupffer cells in the induction of tolerance of orthotopic liver transplantation in rats. Liver Transpl. 2008; 14(6):823-836.
[47] MARTINEZ OM, KRAMS SM. Involvement of Fas-Fas ligand interactions in graft rejection. Int Rev Immunol. 1999;18(5-6):527-546.
[48] Marín LA, MURO M, MOYA-QUILES MR, et al. Study of Fas (CD95) and FasL (CD178) polymorphisms in liver transplant recipients. Tissue Antigens. 2006;67(2):117-126.
[49] VIDYA MK, KUMAR VG, SEJIAN V, et al. Toll-like receptors: significance, ligands, signaling pathways, and functions in mammals. Int Rev Immunol. 2018;2;37(1):20-36.
[50] HOWELL J, GOW P, ANGUS P, et al. Role of toll-like receptors in liver transplantation. Liver Transpl. 2014;20(3):270-280.
[51] MENCIN A, KLUWE J, SCHWABE RF. Toll-like receptors as targets in chronic liver diseases. Gut. 2009;58(5):704-720.
[52] EL-BENDARY M, NAEMATTALAH M, YASSEN A, et al. Interrelationship between Toll-like receptors and infection after orthotopic liver transplantation. World J Transplant. 2020;10(6):162-172.
[53] PENG Y, GONG JP, LIU CA, et al.Expression of toll-like receptor 4 and MD-2 gene and protein in Kupffer cells after ischemia-reperfusion in rat liver graft. World J Gastroenterol. 2004;10(19):2890-2893.
[54] KESHAVARZ Z, ZAREEI N, AFSHARI A, et al. TLR2 and TLR4 mRNA expression levels in liver transplant patients with acute rejection. Immunobiology. 2021;226(4):152107.
[55] OETTING WS, GUAN W, SCHLADT DP, et al. Donor polymorphisms of toll-like receptor 4 associated with graft failure in liver transplant recipients. Liver Transpl. 2012;18(12):1399-1405.
[56] DE LA FUENTE S, CITORES MJ, LUCENA JL, et al. TLR9-1486C/T polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation. Biomark Med. 2019;13(12):995-1004.
[57] 陈凯,史政荣.肝移植免疫耐受的研究进展[J].重庆医学,2020, 49(2):310-314.
[58] MARRA F, TACKE F. Roles for chemokines in liver disease. Gastroenterology. 2014;147(3):577-594.e1.
[59] SCHON HT, WEISKIRCHEN R. Immunomodulatory effects of transforming growth factor-β in the liver. Hepatobiliary Surg Nutr. 2014;3(6):386-406.
[60] GONG J, CAO D, CHEN Y, et al.Role of programmed death ligand 1 and Kupffer cell in immune regulation after orthotopic liver transplantation in rats. Int Immunopharmacol. 2017;48:8-16.
[61] SIMPSON KJ, LUKACS NW, COLLETTI L, et al. Cytokines and the liver. J Hepatol. 1997;27(6):1120-1132.
[62] DINARELLO CA. Historical insights into cytokines. Eur J Immunol. 2007;37 Suppl 1(Suppl 1):S34-S45.
[63] 张安元,刘一鸣,龚建平.Kupffer细胞与肝脏移植的研究进展[J].世界华人消化杂志,2015,23(12):1917-1923.
[64] SAVIER E, LEMASTERS JJ, THURMAN RG. Kupffer cells participate in rejection following liver transplantation in the rat. Transpl Int. 1994;7 Suppl 1:S183-S186.
[65] PAHLAVAN PS, FELDMANN RE JR, ZAVOS C, et al. Prometheus’ challenge: molecular, cellular and systemic aspects of liver regeneration. J Surg Res. 2006;134(2):238-251.
[66] LIAN ZR, XU YF, WANG XB, et al. Suppression of histone deacetylase 11 promotes expression of IL-10 in Kupffer cells and induces tolerance following orthotopic liver transplantation in rats. J Surg Res. 2012;174(2):359-368.
[67] TIAN Y, WANG J, WANG W, et al. Mesenchymal stem cells improve mouse non-heart-beating liver graft survival by inhibiting Kupffer cell apoptosis via TLR4-ERK1/2-Fas/FasL-caspase3 pathway regulation. Stem Cell Res Ther. 2016;7(1):157.
[68] 刘涛,李金政.枯否细胞极化状态在肝移植免疫耐受中的作用[J].器官移植,2021,12(6):687-691.
[69] YOU Y, ZHANG J, GONG J, et al. Mesenchymal stromal cell-dependent reprogramming of Kupffer cells is mediated by TNF-α and PGE2 and is crucial for liver transplant tolerance. Immunol Res. 2015;62(3):292-305.
[70] ZHAO Z, PAN G, TANG C, et al. IL-34 Inhibits acute rejection of rat liver transplantation by inducing Kupffer cell M2 polarization. Transplantation. 2018;102(6):e265-e274.
[71] HU Y, YANG C, SHEN G, et al. Hyperglycemia-triggered sphingosine-1-phosphate and sphingosine-1-phosphate receptor 3 signaling worsens liver ischemia/reperfusion injury by regulating M1/M2 polarization. Liver Transpl. 2019;25(7):1074-1090.
[72] DENG M, WANG J, WU H, et al. IL-4 alleviates ischaemia-reperfusion injury by inducing kupffer cells M2 polarization via STAT6-JMJD3 pathway after rat liver transplantation. Biomed Res Int. 2020;2020: 2953068.
[73] ZHANG W, CAO D, WANG M, et al. XBP1s repression regulates Kupffer cell polarization leading to immune suppressive effects protecting liver allograft in rats. Int Immunopharmacol. 2021;91:107294.
|